Delivery Order SPE2DR25D9231-SPE2DR26FHPB5
Award Date 3/6/26
Potential Completion Date 3/27/26
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $11,670.40 delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for Prolastin C 1,000 mg/20 ml vials under the firm fixed-price Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order has an ultimate completion date of March 4, 2026. No set-aside was applied to this delivery...
- The Defense Logistics Agency issued a $10,200 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Prolastin C 1,000 mg/20 ml under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is priced on a firm fixed-price basis with an ultimate completion date of March 20, 2026. Place of performance is Park Ridge, Illinois. The delivery order calls against the PPV-G GEN V indefinite...
- The Defense Logistics Agency issued a $11,648 delivery order to DMS Pharmaceutical Group Inc. on February 27, 2026, for Prolastin C 1,000 mg/20 ml vials under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is a Defense Logistics Agency pharmaceutical supply contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, for Prolastin C 1,000 mg/20 ml vials with a ceiling value of $23,848.80. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling and performance period through December 31, 2036. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency awarded a $22,524.88 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on January 13, 2026, with an ultimate completion date of February 4, 2026, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This award represents a single delivery...
- The Defense Logistics Agency issued a $16,000 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for Prolastin C 1,000 mg/20 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. Place of performance is Park...
- The Defense Logistics Agency awarded a $36,160.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS...
- The Defense Logistics Agency issued a delivery order valued at $36,097.97 to DMS Pharmaceutical Group Inc. for Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, represents a standalone pharmaceutical supply procurement with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected to...
- The Defense Logistics Agency awarded a $10,230 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on January 27, 2026, with an ultimate completion date of February 18, 2026, was awarded without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, with a ceiling value of $17,922.40 for supply of Prolastin C 1,000 mg/20 ml vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a...